Research location
Langley
British Columbia, Canada
Advertisement
Research activity in Langley
British Columbia, CanadaCureCurrent currently publishes aggregate city-level research activity for this location: 18 trials and 18 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Langley
18 linked trials · page 1 of 1Hockey Fans in Training (Hockey FIT): Improving Men's Health Through the Power of SportNCT03636282 · 2018-11-13 · 1 site observation
COMPLETED
Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients.NCT01966107 · 2013-10-16 · 1 site observation
COMPLETED
Open-Label Long-Term Safety and Efficacy Study of Fixed Dose Combination of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Subjects With Moderate to Severe Essential HypertensionNCT01788358 · 2013-02-14 · 1 site observation
COMPLETED
Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)NCT01572792 · 2012-04-01 · 1 site observation
COMPLETED
Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On MetforminNCT01517373 · 2012-02-01 · 1 site observation
COMPLETED
Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)NCT01437397 · 2011-09-01 · 1 site observation
COMPLETED
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential HypertensionNCT01303783 · 2011-04-01 · 1 site observation
COMPLETED
Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus RegimenNCT01165684 · 2010-10-01 · 1 site observation
COMPLETED
Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 DiabetesNCT01167881 · 2010-08-01 · 1 site observation
COMPLETED
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 DiabetesNCT01068665 · 2010-03-01 · 1 site observation
COMPLETED
Canadian Study of Trandolapril on Blood Pressure in Hypertensive PatientsNCT01078584 · 2008-12-01 · 1 site observation
COMPLETED
Efficacy and Safety of Dapagliflozin, Added to Therapy of Patients With Type 2 Diabetes With Inadequate Glycemic Control on InsulinNCT00673231 · 2008-04-01 · 1 site observation
COMPLETED
Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-NaiveNCT00495469 · 2007-08-17 · 1 site observation
COMPLETED
A Trial of BMS-512148 in Patients With Type 2 Diabetes MellitusNCT00263276 · 2005-12-01 · 1 site observation
COMPLETED
Study In People With Type 2 DiabetesNCT00196989 · 2005-09-01 · 1 site observation
COMPLETED
Study of Muraglitazar Versus Pioglitazone in Type 2 DiabetesNCT00106808 · 2005-08-01 · 1 site observation
COMPLETED
A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II DiabeticsNCT00067951 · 2003-10-17 · 1 site observation
COMPLETED
Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes SubjectsNCT00499707 · 2003-10-08 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.